Help-Line 01233 334879

 

Proventus

Making Life Fairer

 

Working Together to Make a Difference

UK Charity No 1131517

Working together to make a difference

We are a member of the Fund Raising Standards Board

 

We are all volunteers and the advice we receive is also given freely.

 

All donations are used to further the work we do.

Please Donate

 

Join Us

 

Provide Support

Buy At

 

UK Charity

No 1131517

 

Copyright © Proventus 2010

 

Terms & Conditions

 

Multiple Sclerosis

It is important to remember that MS is only one part of a person and not the person.

MS does not represent them, it is not their identity, they are as normal as the next person.  

Find Us Here

You tube
Follow Provpeter on Twitter
You Tube
twitter

Blood Test May Predict Course Of MS

Scientists have discovered a blood test that could predict the course of multiple sclerosis (MS), or even indicate who is likely to develop the condition after a first MS-like attack. The results of the study suggest that differing antibody levels produced in response to the common virus Epstein Barr Virus (EBV), may predict the course of MS.

 

If proven in further studies, this would be the first credible biological indicator, or biomarker, identified for MS that could predict disability progression from a simple blood test. It is hoped the findings will aid the development of better ways to predict who goes on to develop MS after initial MS-like symptoms and help in identifying more effective therapies for the 100,000 people living with MS in the UK.

 

The paper's lead author, Clinical Research Fellow Dr Rachel Farrell, said: "All the participants in our study had previous history of infection with EBV, which has been shown in other studies and is not surprising given that a large majority of the adult population is infected with EBV.

 

"What was surprising is that the levels of a molecule in the blood called anti-EBNA-1 IgG, induced by the virus, were associated with the activity of MS. "The results of this work show that those participants who had new areas of MS damage in the brain also had high levels of the anti-EBNA-1 IgG molecule in their blood." [1]

                                                                                                                                                                                                        

The innovative work was carried out at the Institute of Neurology, UCL and the Institute of Cell and Molecular Biology, Barts and The London Hospitals and was funded by the MS Society

 

1. medicalnewstoday.com

Top of Page